REFERENCES
- Lam CG, Howard SC, Bouffet E, Pritchard-Jones K. Science and health
for all children with cancer. Science. 2019; 363:1182-1186.
- Howard SC, Davidson A, Luna-Fineman S, et al. A framework to develop
adapted treatment regimens to manage pediatric cancer in low- and
middle-income countries: the Pediatric Oncology in Developing
Countries (PODC) Committee of the International Pediatric Oncology
Society (SIOP). Pediatr Blood Cancer. 2018; 64:e26879.
- Sullivan M, Bouffet E, Rodriguez- Galindo C, et al. The COVID-19
pandemic: a rapid global response for children with cancer from SIOP,
COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global. Pediatr
Blood Cancer. 2020; 67:e28409.
- Bouffet E, Challinor J, Sullivan M, Biondi A, et al. Early advice on
managing children with cancer during the COVID-19 pandemic and a call
for sharing experiences. Pediatr Blood Cancer. 2020:e28327
- Gampel B, Troullioud Lucas AG, Broglie L, Gartrell-Corrado RD, et al.
COVID-19 disease in New York City pediatric hematology and oncology
patients. Pediatr Blood Cancer. 2020 Sep;67: e28420
- de Rojas T, Perez Martinez A, Cela E, et al. COVID-19 infection in
children and adolescents with cancer in Madrid. Pediatr Blood Cancer.
2020;67:e28397.
- Yigenoglu TN, Ata N, Altuntas F, et al. The outcome of COVID- 19 in
patients with hematological malignancy. J Med Virol. 2021;93:1099-1104
- Boulad F, Kamboj M, Bouvier N, et al. COVID-19 in children with cancer
in New York City. JAMA Oncol. 2020;6:1459-1460
- Hrusak O, Kalina T, Wolf J, et al. Flash survey on severe acute
respiratory syndrome coronavirus-2 infections in paediatric patients
on anticancer treatment. Eur J Cancer. 2020; 132:11–6
- Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of
coronavirus disease 2019: a model-based analysis. Lancet Infect
Dis. 2020;20: 669-677
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for
mortality of adult inpatients with COVID-19 in Wuhan, China: a
retrospective cohort study. Lancet. 2020;395:1054-1062
- Vijenthira A, Gong IY, Fox TA, Booth S, Cook G, et al. Outcomes of
patients with hematologic malignancies and COVID-19: a systematic
review and meta-analysis of 3377 patients. Blood. 2020;136:2881-2892
- Hamdy R, El-Mahallawy H, Ebeid E. COVID-19 infection in febrile
neutropenic pediatric hematology oncology patients. Pediatr Blood
Cancer. 2021 ;68:e28765
- de Rojas T, Pérez-Martínez A, Cela E, Baragaño M, et al. COVID-19
infection in children and adolescents with cancer in Madrid. Pediatr
Blood Cancer. 2020 ;67:e28397.
- CDC COVID-19 Response Team. Coronavirus disease 2019 in children -
United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly
Rep . 2020;69:422
- Guo, CX., He, L., Yin, JY. et al. Epidemiological and clinical
features of pediatric COVID-19. BMC Med 18, 250
(2020).
- Montoya J, Ugaz C, Alarcon S, Maradiegue E, García J, Díaz R, Zapata
A, Chávez S, Morales R, Ordoñez K, Hernandez E, Reaño R, Gutierrez C,
Vargas MP, Sanchez K, Valdiviezo C, Maza I, Rojas N, Moore C, León E,
Vásquez L. COVID-19 in pediatric cancer patients in a resource-limited
setting: National data from Peru. Pediatr Blood Cancer. 2020 Jul
22:e28610..